ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2023, Vol. 37 ›› Issue (5): 156-161.doi: 10.6040/j.issn.1673-3770.0.2022.258
• Review • Previous Articles Next Articles
ZHU Yu, ZHU Xinhua
CLC Number:
| [1] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. doi:10.4193/Rhin20.600 [2] Lee K, Tai JH, Lee SH, et al. Advances in the knowledge of the underlying airway remodeling mechanisms in chronic rhinosinusitis based on the endotypes: a review[J]. Int J Mol Sci, 2021, 22(2): 910. doi:10.3390/ijms22020910 [3] Wang XD, Zhang N, Bo MY, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5): 1344-1353. doi:10.1016/j.jaci.2016.05.041 [4] Busse WW, Kraft M, Rabe KF, et al. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation[J]. Eur Respir J, 2021, 58(2): 2003393. doi:10.1183/13993003.03393-2020 [5] Avdeeva K, Fokkens W. Precision medicine in chronic rhinosinusitis with nasal polyps[J]. Curr Allergy Asthma Rep, 2018, 18(4): 25. doi:10.1007/s11882-018-0776-8 [6] Md SA, Md KJ, Thibaut van Zele MD P, et al. Endoscopic sinus surgery for type-2 CRS wNP: an endotype-based retrospective study[J]. Laryngoscope, 2019, 129(6): 1286-1292. doi:10.1002/lary.27815 [7] 陶丹丹, 董红军, 褚云锋, 等. 慢性鼻-鼻窦炎伴鼻息肉患者组织嗜酸性粒细胞与嗅觉功能障碍的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388 TAO Dandan, DONG Hongjun, CHU Yunfeng, et al. Correlation between eosinophils and olfactory dysfunction in patients with CRSwNP after nasal operation[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388 [8] Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease[J]. Nat Rev Drug Discov, 2016, 15(1): 35-50. doi:10.1038/nrd4624 [9] Kim HJ, Lim J, Jang YS, et al. Exogenous hydrogen peroxide induces lipid raft-mediated STAT-6 activation in T cells[J]. Cell Physiol Biochem, 2017, 42(6): 2467-2480. doi:10.1159/000480210 [10] Zhu JF. T helper 2(Th2)cell differentiation, type 2 innate lymphoid cell(ILC2)development and regulation of interleukin-4(IL-4)and IL-13 production[J]. Cytokine, 2015, 75(1): 14-24. doi:10.1016/j.cyto.2015.05.010 [11] Chen LQ, Grabowski KA, Xin JP, et al. IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils[J]. J Immunol, 2004, 172(4): 2059-2066. doi:10.4049/jimmunol.172.4.2059 [12] Bal SM, Bernink JH, Nagasawa M, et al. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs[J]. Nat Immunol, 2016, 17(6): 636-645. doi:10.1038/ni.3444 [13] Poposki JA, Klingler AI, Tan BK, et al. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps[J]. Immun Inflamm Dis, 2017, 5(3): 233-243. doi:10.1002/iid3.161 [14] Fan GK, Wang HL, Takenaka H. Eosinophil infiltration and activation in nasal polyposis[J]. Acta Otolaryngol, 2007, 127(5): 521-526. doi:10.1080/00016480600951368 [15] Willebrand R, Dietschmann A, Nitschke L, et al. Murine eosinophil development and allergic lung eosinophilia are largely dependent on the signaling adaptor GRB2[J]. Eur J Immunol, 2018, 48(11): 1786-1795. doi:10.1002/eji.201847555 [16] Pelaia G, Vatrella A, Busceti MT, et al. Role of biologics in severe eosinophilic asthma-focus on reslizumab[J]. Ther Clin Risk Manag, 2016, 12: 1075-1082. doi:10.2147/TCRM.S111862 [17] Delemarre T, De Ruyck N, Holtappels G, et al. Unravelling the expression of interleukin-9 in chronic rhinosinusitis: a possible role for Staphylococcus aureus[J]. Clin Transl Allergy, 2020, 10(1): 41. doi:10.1186/s13601-020-00348-5 [18] Lin H, Lin D, Xiong XS, et al. Expression and regulation of interleukin-9 in chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2015, 29(1): e18-e23. doi:10.2500/ajra.2015.29.4136 [19] Tsicopoulos A, Shimbara A, de Nadai P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis[J]. J Allergy Clin Immunol, 2004, 113(3): 462-469. doi:10.1016/j.jaci.2003.12.009 [20] Shaw JL, Fakhri S, Citardi MJ, et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps[J]. Am J Respir Crit Care Med, 2013, 188(4): 432-439. doi:10.1164/rccm.201212-2227OC [21] Yuan T, Zheng R, Liu J, et al. Role of yes-associated protein in interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps[J]. Allergy, 2021, 76(2): 600-604. doi:10.1111/all.14699 [22] Li X, Huang JC, Chen XH, et al. IL-19 induced by IL-13/IL-17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP-9 expression via ERK/NF-κB signaling pathway[J]. Clin Transl Allergy, 2021, 11(1): e12003. doi:10.1002/clt2.12003 [23] Jiao J, Duan S, Meng N, et al. Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps[J]. Clin Exp Allergy, 2016, 46(3): 449-460. doi:10.1111/cea.12644 [24] Khalmuratova R, Lee MY, Park JW, et al. Evaluation of neo-osteogenesis in eosinophilic chronic rhinosinusitis using a nasal polyp murine model[J]. Allergy Asthma Immunol Res, 2020, 12(2): 306-321. doi:10.4168/aair.2020.12.2.306 [25] Khalmuratova R, Shin HW, Kim DW, et al. Interleukin(IL)-13 and IL-17A contribute to neo-osteogenesis in chronic rhinosinusitis by inducing RUNX2[J]. EBioMedicine, 2019, 46: 330-341. doi:10.1016/j.ebiom.2019.07.035 [26] PhD SMK, Bs IB, Ms HK, et al. Interleukin 13(IL-13)alters hypoxia-associated genes and upregulates CD73[J]. Int Forum Allergy Rhinol, 2020, 10(9): 1096-1102. doi:10.1002/alr.22630 [27] Huang ZQ, Liu J, Ong HH, et al. Interleukin-13 alters tight junction proteins expression thereby compromising barrier function and dampens Rhinovirus induced immune responses in nasal epithelium[J]. Front Cell Dev Biol, 2020, 8: 572749. doi:10.3389/fcell.2020.572749 [28] Schmidt H, Braubach P, Schilpp C, et al. IL-13 impairs tight junctions in airway epithelia[J]. Int J Mol Sci, 2019, 20(13): 3222. doi:10.3390/ijms20133222 [29] Lam EPS, Kariyawasam HH, Rana BMJ, et al. IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa[J]. J Allergy Clin Immunol, 2016, 137(5): 1514-1524. doi:10.1016/j.jaci.2015.10.019 [30] Luo XL, Li CL, Wang YM, et al. Interleukin-33 promotes Th2/Th17 response in eosinophilic and non-eosinophilic nasal polyps[J]. ORL J Otorhinolaryngol Relat Spec, 2020, 82(1): 34-39. doi:10.1159/000503976 [31] Iinuma T, Okamoto Y, Yamamoto H, et al. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis[J]. Ann Allergy Asthma Immunol, 2015, 114(4): 289-298. doi:10.1016/j.anai.2015.01.013 [32] Swaidani S, Bulek K, Kang ZZ, et al. T cell-derived Act1 is necessary for IL-25-mediated Th2 responses and allergic airway inflammation[J]. J Immunol, 2011, 187(6): 3155-3164. doi:10.4049/jimmunol.1002790 [33] Wu L, Zepp JA, Qian W, et al. A novel IL-25 signaling pathway through STAT5[J]. J Immunol, 2015, 194(9): 4528-4534. doi:10.4049/jimmunol.1402760 [34] Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps(liberty np sinus-24 and liberty np sinus-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials[J]. Lancet, 2019, 394(10209): 1638-1650. doi:10.1016/S0140-6736(19)31881-1 [35] Wang Q, Sun Q, Chen QG, et al. Efficacy and safety of anti-interleukin-5 therapies in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomized controlled trials[J]. Int Arch Allergy Immunol, 2022, 183(7): 732-743. doi:10.1159/000521859 [36] Lee MY, Kim DW, Shin HW. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps[J]. Curr Opin Allergy Clin Immunol, 2017, 17(1): 17-22. doi:10.1097/ACI.0000000000000332 [37] Md YH J, Hyun-Jin Cho MD P, Md YJJ, et al. Therapeutic effects of intranasal tofacitinib on chronic rhinosinusitis with nasal polyps in mice[J]. Laryngoscope, 2021, 131(5): E1400-E1407. doi:10.1002/lary.29129 |
| [1] | FENG Sicong, YU Xiaolan, LOU Dan. Evaluation of the effect of Messerklinger middle turbinate plasty on chronic rhinosinusitis with nasal polyps based on the expression of Ki67 and GM-CSF in vesicular tissue [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 31-39. |
| [2] | ZHAI Xuechun, BIAN Xin, CHEN Jingcai, DENG Jiayu, YE Zi, YANG Pingli. Characteristics and influencing factors of anxiety and depression in patients with chronic frontal sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 35-43. |
| [3] | LI Yangsong, YUAN Fayang, YANG Yan, ZHANG Tian, YU Guodong. Bibliometric analysis of biologic agents for the treatment of chronic rhinosinusitis based on the Web of Science database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 54-64. |
| [4] | ZHANG Jiaqi, YUAN Ye, HONG Chen, GU Min, CHENG Lei, LU Meiping. Mendelian randomization study of gut microbiota, chronic sinusitis, and nasal polyps: Causal relationships and metabolite-mediated effects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 49-60. |
| [5] | YIN Zhenqian, HUANGFU Hui. Kimura disease:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 104-107. |
| [6] | ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147. |
| [7] | ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134. |
| [8] | ZHANG Guangling, CHEN Xingxue, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao,WANG Guangke. The expression and function of Tespa1 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 35-42. |
| [9] | CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50. |
| [10] | WANG Wenqing, ZHANG Dan, ZHU Mengdi, WANG Luyang, YANG Peipei, SUN Sisi, ZHANG Qiumin, ZHOU Hui. Changes of clinical and histopathological characteristics in recurrent chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 46-53. |
| [11] | WANG Aowei, SHI Wenjie. Study on correlation between traditional Chinese medicine syndrome types and TFH cell related factors in CRSwNP [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 54-60. |
| [12] | ZHANG Jie, NIMA Jizong, XU Xiaodong, ZHOU Jing, LIU Jianmin, LUO Yirui, DU Jintao, BA Luo. Effect of Crocin on Type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 61-67. |
| [13] | SHI Zhonggang, CAI Xiaolan, LI Xuezhong, ZHANG Liqiang, FENG Xin. Maxillary cyst with inverted papilloma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 123-129. |
| [14] | ZHANG Yunqiu, REN Xiumin, XU Ou, DONG Jinhui, WANG Jianxing. Research progress on omalizumab targeted therapy for chronic sinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 136-140. |
| [15] | LI Ting, ZHAO Chong, WU Xian. The relationship between miR-34a expression in nasal mucosa tissue and postoperative recurrence in patients with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 20-25. |
|
||